Evaluation of Dithiocarbamate-Modified Silica for Cisplatin Removal from Water

Author:

Lombana Fraguela Rachel1,Ricardo Garcia José Alejandro2,Villanueva Tagle Margarita Edelia2,Pomares Alfonso Mario Simeón1,Cracchiolo Maria3,Kovačević Anđela3,Tolazzi Marilena3,Melchior Andrea3ORCID,Sanadar Martina3ORCID

Affiliation:

1. Institute of Materials Science and Technology (IMRE), University of Havana, Calle Zapata s/n e/Mazon y G, Havana 10400, Cuba

2. Faculty of Chemistry, University of Havana, Havana 10400, Cuba

3. Dipartimento Politecnico di Ingegneria e Architettura, Università di Udine, via del Cotonificio 108, 33100 Udine, Italy

Abstract

Despite the globally increasing use of platinum-based cytostatic drugs in the treatment of several types of cancer, only limited attention has been paid to developing a treatment for contaminated liquid samples originating from hospitals, laboratories and manufacturing facilities before and after their administration. In this work, we assess the efficiency of a low-cost adsorbent material, a dithiocarbamate-functionalized silica, in removing cisplatin from a solution containing it in the 0.5–150 mg L−1 concentration range. The advantage of having a surface-functionalized silica is that adsorption can occur by either non-covalent interaction or surface complexation. In the latter case platinum(II) is de-complexed and the original drug is no longer present. Adsorption occurs through a first rapid step, followed by a second slower process. This is likely due to the fact that in our operating conditions (0.9% w/v NaCl), only the original compound is present, for which ligand substitution is known to proceed slowly. The interesting performance, even at low metal concentration, and facile synthesis of the material mean it could be adapted for other applications where the recycling of platinum can be realized.

Publisher

MDPI AG

Subject

Process Chemistry and Technology,Chemical Engineering (miscellaneous),Bioengineering

Reference83 articles.

1. Cancer statistics, 2020;Siegel;CA Cancer J. Clin.,2020

2. WHO (2022, December 01). IARC Cancer Tomorrow. Available online: https://gco.iarc.fr/tomorrow/en.

3. New insights on cytostatic drug risk assessment in aquatic environments based on measured concentrations in surface waters;Gouveia;Environ. Int.,2019

4. 9,9-Difluorobispidine Analogues of Cisplatin, Carboplatin, and Oxaliplatin;Mitra;Inorg. Chem.,2017

5. Metal complexes in cancer therapy—An update from drug design perspective;Ndagi;Drug Des. Devel. Ther.,2017

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3